 |
|
Prostate Cancer : Signature of a partnership agreement between Beaufour Ipsen and UroGene
July 17, 2002The pharmaceutical group Beaufour Ipsen and the biopharmaceutical company UroGene have just signed a partnership agreement for the functional and clinical evaluation of a class of molecules in the field of prostate cancer.
UroGene will be contributing its molecular genomic know-how, its biological and clinical expertise, and its biological resources and data base, in order to implement this programme.
"This agreement is very pertinent to the Beaufour Ipsen Group strategy since oncology is one of our major lines of therapeutic research. This agreement with UroGene regarding an important medical application is very satisfactory" stated Christophe Thurieau, Director of Research of the Henri Beaufour Institute. "We are convinced that evaluating our molecules for prostate cancer will open the way to extremely promising new therapeutic possibilities. Cancer of the prostate concerns millions of men the world over. Combining our joint expertise and developing the tools required to provide specialist care will give new hope to patients and clinicians involved in the management of this disease."
"We are particularly pleased with the Beaufour Ipsen decision to join forces with us. They are very prominent in the treatment of prostatic cancer and this agreement concurs with our strategy - an integrated oncological and urological approach. It is also a further demonstration that the means and know-how available to us can advance the development of new therapeutics" declared Philippe Berthon, President and Chief Scientific Officer of UroGene. "Further to our own therapeutic development plans - from gene to treatment - in the field of urological tumours, such cooperative work on new molecules can provide timely solutions in the quest for innovative treatment at the clinical stage.?
Present in over 80 countries with a total staff of 3423, the Beaufour Ipsen Group had a turnover of ?704 million in 2001, 57% of which was outside France. The Company specialises in oncology, haematology, neurology and endocrinology and has a portfolio of 30 products which are either peptides, derived from biotechnology, or based on natural sources. In 2001, 16.4% of Beaufour Ipsen`s turnover is reinvested in Research and Development. R&D is focused on four major areas (biologicals, peptides, therapeutic agents of low molecular weight and drug delivery technology) and is carried out from 4 research centres (Paris, Boston, Barcelona and London) by an international network of around 500 scientific staff. The Group is directing its research efforts towards disabling diseases where current treatments remain unsatisfactory. Beaufour Ipsen currently has a pipeline of 15 projects in development. The Group has also set up research partnerships with prestigious universities in the USA and Europe, mainly in France and in the United Kingdom.
Centre de Recherche des Pathologies Prostatique et UroGene (CEREPP)
Prostate Cancer Current Events and Prostate Cancer News RSSDrop in cancer deaths tied primarily to gains in behavior and screening
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
Prostate cancer spurs new nerves
Prostate cancer - and perhaps other cancers - promotes the growth of new nerves and the branching axons that carry their messages, a finding associated with more aggressive tumors, said researchers from Baylor College of Medicine in the first report of the phenomenon that appears today in the journal Clinical Cancer Research.
Relationship between prostate information and lower urinary-tract symptoms evident
In the December issue of European Urology (http://www.elsevier.com/locate/eururo) Dr. Curtis Nickel and associates report on the evidence of a relationship between prostate inflammation and lower urinary tract symptoms (LUTS) in men enrolled in the REDUCE trial.
A card-swipe for medical tests
University of Utah scientists successfully created a sensitive prototype device that could test for dozens or even hundreds of diseases simultaneously by acting like a credit card-swipe machine to scan a card loaded with microscopic blood, saliva or urine samples.
Media coverage of lung cancer is increasing, and increasingly negative, new report shows
CancerCare today announced that despite an overall increase in news reporting on lung cancer, the overall tone of lung cancer media coverage has become significantly more negative.
Supercomputer provides massive computational boost to biomedical research at TGen
In less time than the blink of an eye, the Translational Genomics Research Institute's new supercomputer at Arizona State University can do operations equal to every dollar in the recent Wall Street bailout.
Prostate cancer gene test provides new early detection
Prostate cancer (PCa) is one of the most common male cancers in the Western world. Currently, early detection of PCa depends on an abnormal digital rectal examination and an elevated prostate-specific-antigen (PSA) level requiring a prostate biopsy, often associated with anxiety, discomfort, complications, and heavy expenses.
New Catheter-less Technique May Ease the Pain and Discomfort of Prostate Cancer Recovery
To ease the pain of recovery following prostate cancer surgery, physician-scientists have developed an innovative and patient-friendly approach that eliminates the use of a penile urinary catheter.
Racial disparities decline for cancer in Missouri
Cancer death rates in the United States are highest among African Americans, but a new report shows that in Missouri the disparity in cancer incidence and death between African Americans and whites is declining.
OHSU Cancer Institute researchers study breathing during radiation
Oregon Health & Science University researchers have determined exactly how much breathing affects prostate movement during radiation treatment.
More Prostate Cancer Current Events and Prostate Cancer News Articles
 | Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition by Patrick C. Walsh, Janet Farrar Worthington EVERY MAN NEEDS THIS BOOK! Each year, more than 200,00 American men are diagnosed with prostate cancer. The good news is that more men are being cured of this disease than ever before. Now in a revised second edition, this lifesaving guide by Dr. Patrick Walsh and ard-winning science writer Janet Farrar Worthington offers a message of hope to every man facing this illness. Prostate cancer is... |
 | You Can Beat Prostate Cancer by Robert J. Marckini The task of choosing the right prostate cancer treatment is daunting. It is further complicated by conflicting information the patient receives from physicians and the Internet. This book is written by a prostate cancer survivor who now runs an international prostate cancer support group. It's about his journey and the important things he learned along the way. It is the book the author wishes... |
 | Eat to Beat Prostate Cancer Cookbook by David Ricketts Prostate cancer is now the most common nonskin cancer among men in the United States. In 2005 alone, 250,000 new cases were diagnosed, and that number is certain to rise with each passing year. No one is more aware of this than David Ricketts, experienced cookbook author and recent prostate cancer survivor.Shortly after surgery and radiation treatments, Ricketts began to research food and... |
 | Prostate Cancer for Dummies by Paul H. Lange, Christine Adamec, Christine Adamec Hearing that you have prostate cancer, or even that you may have it, is very scary. But this disease, in many cases, is curable. Even if you have advanced cancer that's spread beyond the prostate, many treatments help extend your life for years. You need good information to help you with the decisions that lie ahead, and this book provides you with this information. Prostate Cancer For... |
 | Prostate And Cancer: A Family Guide To Diagnosis, Treatment And Survival (3rd Edition) by Sheldon Marks The major reference book for men concerned about or diagnosed with prostate cancer. Prostate cancer has become the most-diagnosed cancer in America and the second leading killer of men. Sadly, more than 189,000 men will be diagnosed with the disease in 2002. Dr. Sheldon Marks, a specialist in the diagnosis and treatment of prostate cancer, is the authority that many have come to depend on--both... |
 | Surviving Prostate Cancer Without Surgery by Bradley Hennenfent The niche bestseller "Surviving Prostate Cancer Without Surgery" begins with the shooting of a urologist and includes a World War II Battle. The book exposes the big lie about radical prostate surgery, is filled with cartoons and simple diagrams, and is written for the average layperson in easy-to-understand style. "Surviving Prostate Cancer Without Surgery" quotes Dr. Gary Onik, M.D.,... |
 | Prostate Cancer: A Cleveland Clinic Guide (Cleveland Clinic Guides) by Eric A Klein In this Cleveland Clinic Guide, one of the world's most respected experts explains the anatomy and function of the prostate gland and provides a thorough review of prostate cancer. Some of the topics covered include risk factors, symptoms, diagnosis - including tests and procedures, treatment choices, and other diseases of the... |
 | A Primer on Prostate Cancer: The Empowered Patient's Guide by Stephen Strum, Donna L. Pogliano ¡§A Primer on Prostate Cancer, The Empowered Patient¡¦s Guide¡¨ is a basic resource to be used by patients and physicians when there has been a diagnosis of prostate cancer. It outlines a strategy of disease management that is designed to maximize outcomes for the patient and his loved ones. All aspects of diagnosis and testing are discussed; all currently approved treatments for prostate... |
| 100 Questions & Answers About Prostate Cancer by MD. , John Heaney, MD. , Cliff Gill Pamela Ellsworth | |
 | The Prostate Cancer Treatment Book by Peter Grimm, John Blasko, John Sylvester The latest and most progressive treatment advice from prostate cancer experts at the nation's top medical centers For each of the nearly 200,000 Americans diagnosed with prostate cancer annually, the months following the diagnosis are a time of momentous decisions and enormous emotional strain. This book offers readers complete answers to all their questions about the best treatment options for... |
| © 2008 BrightSurf.com |